Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Linking lifestyle to longevity: How diet and hypertension sway risks for heart disease and cancer

Study reviews epidemiological evidence linking modifiable risk factors like diet and hypertension to both cardiovascular disease (CVD) and cancer, suggesting a shared pathophysiology and potential strategies for simultaneous prevention and management.

11 Apr 2024

Study shows GHRH antagonist's role in AML drug resistance

A new research paper was published in Oncotarget's Volume 15 on April 8, 2024, entitled, "Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia."

10 Apr 2024

New lab assay could make diagnosis and treatment of lung cancer easier

A new lab assay developed by researchers at Fred Hutch Cancer Center could make diagnosis and treatment of small-cell lung cancer and non-small cell lung cancer easier.

10 Apr 2024

AI improves breast cancer screening accuracy, reduces false alarms

Using artificial intelligence (AI) to supplement radiologists' evaluations of mammograms may improve breast-cancer screening by reducing false positives without missing cases of cancer, according to a study by researchers at Washington University School of Medicine in St. Louis and Whiterabbit.ai, a Silicon Valley-based technology startup.

10 Apr 2024

Three early-phase clinical studies show promising initial data for patients with lymphoma, gastric cancers

Three early-phase clinical studies presented by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2024 show promising initial data for patients with lymphoma, gastric or gastroesophageal junction cancers, and specific molecularly selected tumors.

10 Apr 2024

Deciphering cancer plasticity:Insights from MSK research

About 90% of deaths from cancer are a result of metastasis -; that is, from cancer's ability to spread from an initial primary tumor to seed new tumors throughout the body, often in the lungs, liver, and brain.

10 Apr 2024

Research identifies how leukemia develops resistance to first line treatments

Relapses in a common form of leukemia may be preventable following new research which has identified how the cancer develops resistance to first line treatments.

9 Apr 2024

Personalized anti-tumor vaccine enhances immunotherapy for liver cancer

Adding a personalized anti-tumor vaccine to standard immunotherapy is safe and about twice as likely to shrink cancer as standard immunotherapy alone for patients with hepatocellular carcinoma, the most common type of liver cancer, according to a clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center and its Convergence Institute.

8 Apr 2024

Novel therapeutic approach identified for overcoming resistance in B-cell leukemia

Despite having an overall survival rate of 94%, B-cell acute lymphoblastic leukemia (B-ALL), the most common childhood cancer, can prove challenging to treat, with survival among relapsed or resistant cases falling between 30-50%.

8 Apr 2024

Depression impacts survival rates and quality of life for women with breast cancer

A new study presented at the European Psychiatric Association Congress 2024 sheds light on the significant impact of depression on the survival rates and quality of life for women diagnosed with breast cancer.

8 Apr 2024

Expanding research and clinical options for children with cancer

In this interview, Dr. Church, the Molecular and Pediatric Pathologist at Boston Children's Hospital, talks to NewsMedical about their work in pediatric oncology, and the need to expand research and clinical options for children with cancer.

From Tecan 8 Apr 2024

UCLA study finds pre-surgery immunotherapy safe for pancreatic cancer patients

A pilot study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that for people with borderline resectable pancreatic cancer, administrating an immunotherapy drug in combination with chemotherapy before surgery is safe and may improve long-term outcomes.

5 Apr 2024

Innovative breast cancer treatment sequence yields positive results

Researchers at The University of Texas MD Anderson Cancer Center showed that altering the sequence of breast cancer treatment to administer radiation before mastectomy allowed for concurrent breast reconstruction surgery, which reduced the number of operations required, minimized treatment delays and improved patient satisfaction.

5 Apr 2024

Novel combination therapy shows promise in difficult-to-treat endometrial cancer, study finds

In a small, investigator-initiated phase 2 study by Dana-Farber Cancer Institute investigators, a novel combination of an antibody-drug conjugate and an immune checkpoint inhibitor showed notable activity in pre-treated patients with a difficult-to-treat form of endometrial cancer.

5 Apr 2024

Lancet Commission predicts sharp increase in global prostate cancer cases

Cases of prostate cancer are projected to double from 1.4 million per year in 2020 to 2.9 million per year by 2040, with low- and middle-income countries (LMICs) predicted to see the highest increases in cases, according to The Lancet Commission on prostate cancer which will be launched by a presentation at the European Association of Urology Congress.

4 Apr 2024

Study shows increased smoking cessation rates among e-cigarette users

A new paper in Nicotine & Tobacco Research, published by Oxford University Press, finds that smokers who switch to electronic cigarettes are now more likely to stop smoking regular cigarettes.

3 Apr 2024

Advances and hurdles: The impact of AI on oncology care efficiency and mortality rates

The benefits and limitations of precision medicine techniques in oncology research and treatment.

3 Apr 2024

Bio-Rad launches first ultrasensitive multiplexed digital PCR assay for breast cancer mutation detection in clinical research

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced the launch of its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ESR1 Mutation Detection Kit.

From Bio-Rad Laboratories 3 Apr 2024

Advancing osteosarcoma prognosis with AI-assisted tumor cell density analysis

Researchers at Kyushu University have developed and validated a machine-learning model that can accurately evaluate the density of surviving tumor cells after treatment in pathological images of osteosarcoma-;the most prevalent malignant bone tumor.

2 Apr 2024

Study reveals immune cell levels as prognostic marker in early-stage triple-negative breast cancer

A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not treated with chemotherapy.

2 Apr 2024

Oncology News and Research

Further Reading

Linking lifestyle to longevity: How diet and hypertension sway risks for heart disease and cancer

Study shows GHRH antagonist's role in AML drug resistance

New lab assay could make diagnosis and treatment of lung cancer easier

AI improves breast cancer screening accuracy, reduces false alarms

Three early-phase clinical studies show promising initial data for patients with lymphoma, gastric cancers

Deciphering cancer plasticity:Insights from MSK research

Research identifies how leukemia develops resistance to first line treatments

Personalized anti-tumor vaccine enhances immunotherapy for liver cancer

Novel therapeutic approach identified for overcoming resistance in B-cell leukemia

Depression impacts survival rates and quality of life for women with breast cancer

Expanding research and clinical options for children with cancer

UCLA study finds pre-surgery immunotherapy safe for pancreatic cancer patients

Innovative breast cancer treatment sequence yields positive results

Novel combination therapy shows promise in difficult-to-treat endometrial cancer, study finds

Lancet Commission predicts sharp increase in global prostate cancer cases

Study shows increased smoking cessation rates among e-cigarette users

Advances and hurdles: The impact of AI on oncology care efficiency and mortality rates

Bio-Rad launches first ultrasensitive multiplexed digital PCR assay for breast cancer mutation detection in clinical research

Advancing osteosarcoma prognosis with AI-assisted tumor cell density analysis

Study reveals immune cell levels as prognostic marker in early-stage triple-negative breast cancer

Cancer Research eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News